Sterling Capital Management LLC Sells 10,563 Shares of Masimo Corporation $MASI

Sterling Capital Management LLC reduced its stake in shares of Masimo Corporation (NASDAQ:MASI) by 97.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 322 shares of the medical equipment provider’s stock after selling 10,563 shares during the quarter. Sterling Capital Management LLC’s holdings in Masimo were worth $57,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of MASI. Global Retirement Partners LLC bought a new position in shares of Masimo during the fourth quarter worth $27,000. Aster Capital Management DIFC Ltd bought a new stake in Masimo in the 4th quarter valued at $28,000. Los Angeles Capital Management LLC bought a new stake in Masimo in the 4th quarter valued at $31,000. Rothschild Investment LLC lifted its stake in Masimo by 12,950.0% in the 4th quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock worth $34,000 after purchasing an additional 259 shares in the last quarter. Finally, Torren Management LLC purchased a new stake in Masimo in the 4th quarter worth $35,000. Institutional investors own 85.96% of the company’s stock.

Masimo Price Performance

Shares of Masimo stock opened at $179.95 on Friday. The stock has a market cap of $9.42 billion, a price-to-earnings ratio of -17.07, a price-to-earnings-growth ratio of 1.82 and a beta of 1.11. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.45 and a current ratio of 2.68. The stock has a 50 day moving average price of $179.25 and a 200-day moving average price of $165.98. Masimo Corporation has a one year low of $125.94 and a one year high of $179.99.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on MASI. Weiss Ratings upgraded Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Wednesday, May 6th. Raymond James Financial downgraded Masimo from an “outperform” rating to a “market perform” rating in a research report on Friday, March 27th. Finally, Wells Fargo & Company raised Masimo to a “hold” rating in a research note on Wednesday, March 18th. Nine research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $180.40.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.